Adult vaccination, part 1: vaccines indicated by age. Teaching Immunization for Medical Education (TIME) Project
- PMID: 11032192
Adult vaccination, part 1: vaccines indicated by age. Teaching Immunization for Medical Education (TIME) Project
Abstract
The morbidity and mortality of vaccine-preventable diseases among adults are high, particularly among populations at high risk because of underlying medical conditions. Influenza vaccination is recommended annually, optimally during campaigns held between October and mid-November, for all persons 50 years and older and for younger persons with high-risk conditions. Because of production delays, influenza vaccination campaigns are delayed until November of this year. Pneumococcal polysaccharide vaccination is recommended for healthy persons 65 years and older and younger persons with high-risk conditions. A 3-dose series of adult tetanus and diphtheria toxoids (Td) is recommended for those who have not had a primary series or whose vaccination history is uncertain. Adults who have completed the primary vaccination series should receive a booster dose of Td vaccine every 10 years. Specific strategies for improving the rate of these vaccinations have been developed for medical offices and clinics, hospitals, and other health care institutions, and other settings where there is high risk of vaccine-preventable disease.
Similar articles
-
Adult vaccination, part 2: vaccines for persons at high risk. Teaching Immunization for Medical Education (TIME) Project.J Fam Pract. 2000 Sep;49(9 Suppl):S51-63; quiz S64. J Fam Pract. 2000. PMID: 11032193 Review.
-
Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.MMWR Morb Mortal Wkly Rep. 2004 Nov 5;53(43):1007-12. MMWR Morb Mortal Wkly Rep. 2004. PMID: 15525897
-
State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.MMWR Morb Mortal Wkly Rep. 2007 Sep 21;56(37):953-9. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17882124
-
Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.Pediatrics. 2008 Apr;121(4):e1016-31. doi: 10.1542/peds.2008-0160. Pediatrics. 2008. PMID: 18381500 Review.
-
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28. Pediatrics. 2006. PMID: 16382131
Cited by
-
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.Vaccine. 2009 Oct 19;27(44):6234-8. doi: 10.1016/j.vaccine.2009.07.107. Epub 2009 Aug 15. Vaccine. 2009. PMID: 19686692 Free PMC article.
-
The Saudi Thoracic Society guidelines for influenza vaccinations.Ann Thorac Med. 2015 Oct-Dec;10(4):223-30. doi: 10.4103/1817-1737.167065. Ann Thorac Med. 2015. PMID: 26664559 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical